摘要
随访了２１３例不能切除的原发性肝癌动脉内治疗的病例。采用以下三种方式：（１）化疗药物灌注（ＨＡＩ组）；（２）碘油抗癌药乳剂栓塞（Ｌｐ－ＴＡＥ组）；（３）碘油乳剂加明胶海绵栓塞（Ｌｐ－ＴＡＥ＋ＧＳ组）。Ｌｐ－ＴＡＥ＋ＧＳ组、Ｌｐ－ＴＡＥ组和ＨＡＩ组，各组１年生存率分别为４２．４％、２７．５％和６．４％（Ｐ＝０．００４７），合并门静脉瘤栓的病例其半年、１年生存率分别为６８．９％和１８．０％。
Two hundreds and thirteen patients with unresectable hepatocellular carcinoma were followed up after transarterial treatment. The following modalities were selected:1) hepaticoarte- rial chemotherapy(HAI group); 2) chemoembolization with oily anticancer agent ( Lp- TAE group); 3)embolization with oily anticancer agent and Gelfoam(Lp- TAE +GS group, one year survial rate was 42.4%in lp-TAE +GS gruop,27.5%in Lp-TAE group and 6.4%in HAI group(P=0. 0047 ). Six and 12 month survival rates in the cases with portal vein trunk and/ormain branches occlusion were 68.9%and 18.0%, respectively.
出处
《解放军医学杂志》
CAS
CSCD
北大核心
1994年第1期29-31,共3页
Medical Journal of Chinese People's Liberation Army
关键词
肝肿瘤
肝动脉栓塞
治疗
Hepatic tumor
Hepatic artery embolization
Therapy
